Real time Form 13D and 13G transaction reports:
- Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company's equity securities.
- Due to inconsistent filing format, it is highly recommended that you read the orignal filing form.
- Shares have beem adjusted for stock split.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
- Peter Lynch
What is insider trading>>
| Reported DateTime | Transaction Date | Type | Company Symbol | Filed By Symbol | Shares Owned % Owned | Shares Vs. Prev Report | View |
| 2026-02-06 4:14 pm Purchase | 2026-01-30 | 13D | KALA BIO, Inc. KALA | David E. Lazar | 49,500,000 5.180% | 49,500,000 (New Position) | Filing History |
| 2026-01-29 7:38 pm Purchase | 2025-10-21 | 13D | NovaBay Pharmaceuticals, Inc. NBY | David E. Lazar | 6,388,000 4.990% | 4,885,920 (+325.28%) | Filing History |
| 2026-01-26 6:18 pm Purchase | 2026-01-16 | 13G | Universal Safety Products, Inc. UUU | David E. Lazar | 156,396 6.760% | 156,396 (New Position) | Filing History |
| 2025-10-17 5:29 pm Purchase | 2025-10-16 | 13D | NovaBay Pharmaceuticals, Inc. NBY | David E. Lazar | 1,502,080 19.990% | 302,032 (+25.17%) | Filing History |
| 2025-08-26 4:11 pm Purchase | 2025-08-19 | 13D | NovaBay Pharmaceuticals, Inc. NBY | David E. Lazar | 1,200,048 19.990% | 1,200,048 (New Position) | Filing History |
| 2025-08-19 12:03 pm Purchase | 2025-08-15 | 13G | Matinas BioPharma Holdings, Inc. MTNB | David E. Lazar | 545,000 9.810% | 545,000 (New Position) | Filing History |
| 2025-08-08 10:52 am Sale | 2025-08-05 | 13D | Cyclacel Pharmaceuticals, Inc. CYCC | David E. Lazar | 0 0.000% | -129,629 (Position Closed) | Filing History |
| 2025-08-04 7:24 pm Sale | 2025-07-30 | 13D | Cyclacel Pharmaceuticals, Inc. CYCC | David E. Lazar | 129,629 8.180% | -32,959 (-20.27%) | Filing History |
| 2025-03-10 5:28 pm Sale | 2025-02-18 | 13D | Minim, Inc. MINM | David E. Lazar | 2,802,254 35.100% | -4,707,226 (-62.68%) | Filing History |
| 2025-02-28 4:46 pm Purchase | 2025-02-06 | 13D | Cyclacel Pharmaceuticals, Inc. CYCC | David E. Lazar | 162,588 15.840% | 162,588 (New Position) | Filing History |
| 2024-12-31 4:57 pm Purchase | 2024-12-26 | 13D | Minim, Inc. MINM | David E. Lazar | 7,509,480 78.300% | 9,113 (+0.12%) | Filing History |
| 2024-11-25 4:41 pm Sale | 2024-11-21 | 13D | LQR House Inc. YHC | David E. Lazar | 0 0.000% | -31,481 (Position Closed) | Filing History |
| 2024-11-15 5:00 pm Purchase | 2024-10-21 | 13D | Minim, Inc. MINM | David E. Lazar | 7,500,367 84.900% | 427,500 (+6.04%) | Filing History |
| 2024-10-21 9:02 pm Purchase | 2024-10-15 | 13D | LQR House Inc. YHC | David E. Lazar | 31,481 19.740% | 31,481 (New Position) | Filing History |
| 2024-08-01 5:25 pm Sale | 2024-07-30 | 13D | OpGen, Inc. OPGN | David E. Lazar | 10,000 13.000% | -239,086 (-95.99%) | Filing History |
| 2024-07-24 5:29 pm Unchanged | 2024-07-22 | 13D | Minim, Inc. MINM | David E. Lazar | 7,072,867 84.100% | 0 (Unchanged) | Filing History |
| 2024-04-25 5:43 pm Purchase | 2024-04-23 | 13D | OpGen, Inc. OPGN | David E. Lazar | 249,086 16.800% | 10,000 (+4.18%) | Filing History |
| 2024-04-08 4:05 pm Unchanged | 2024-04-05 | 13D | OpGen, Inc. OPGN | David E. Lazar | 239,086 19.900% | 0 (Unchanged) | Filing History |
| 2024-04-01 4:05 pm Purchase | 2024-03-25 | 13D | OpGen, Inc. OPGN | David E. Lazar | 239,086 19.900% | 239,086 (New Position) | Filing History |
| 2024-02-29 7:07 pm Purchase | 2024-02-27 | 13D | Minim, Inc. MINM | David E. Lazar | 7,072,867 82.500% | 5,600,000 (+380.21%) | Filing History |